Table 1:

Demographics and baseline characteristics of patients treated with pexidartinib

Characteristic		Number of patients (n=16)
Age (years)	Min., Quartiles, Max.	4, 14.5, 16, 20, 21
Sex	Female/Male	7/9
Race	White	10
	African American	3
	Asian	1
	Hispanic	2
Performance Status (%)	Min., Quartiles, Max.	60, 80, 90, 90, 90
Tumor Type	Sarcomas (Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumor)	8
	Neurofibromatosis type 1 (NF1) Plexiform Neurofibroma	3
	Central Nervous System tumors	3
	Acute myeloid leukemia	1
	Peritoneal mesothelioma	1
Prior Therapies	Surgery	13
	Chemotherapy	12
	Radiation	9
	Immunotherapy	5
	Targeted therapy	5
	None	1